Skip to main content

Table 3 Multivariate stepwise Cox regression analysis with Hazard ratio

From: Moxifloxacin monotherapy versus combination therapy in patients with severe community-acquired pneumonia evoked ARDS

 

p-value

HR (95% CI)

Antibiotic regime

 Other antibiotic therapy

 Moxifloxacin monotherapy

0.86

 

 Moxifloxacin combination-therapy

0.99

 

Sex

0.653

 

Age

0.029

1.03 (1.00–1.05)

BMI

0.042

0.95 (0.90–1.00)

History of prior pulmonary disease

0.481

 

History of prior cardiovascular disease

0.027

2.12 (1.06–4.35)

ECMO-Therapy

0.222

 

Dialysis

0.005

2.48 (1.31–4.71)

Horowitz-Index upon ICU admission

0.987

 

SAPS-II

0.313

 

LIS

0.477

 

SOFA-Score

0.358

 
  1. HR hazard ratio (specified in case of significant p-value of multivariate stepwise Cox regression analysis), CI confidence interval, BMI body-mass-index, ECMO extracorporeal membrane Oxygenation, SPAS: simplified acute physiology score, LIS Lung-Injury-Score, SOFA Sepsis-related organ failure assessment; Horowitz-Index: pO2/FiO2